Since 2006, the human papillomavirus ( HPV ) has been suggested for girls and young women to cut their risks of developing cervical cancer. Young men are also being urged to complete the 3-shot series.

The link between viruses that cause hepatitis and the development of cancer is believed to be why several areas in Asia have higher rates of liver cancer. New research indicates that may not be the full story.

The human papilloma virus (HPV) has surpassed smoking, drinking and poor diet as the leading cause of oral cancers in this country. New research is showing that people with HPV oral cancers have a better outlook than those whose oral cancers are not caused by HPV. Findings from a review of a large Danish database suggest that people with HPV-positive oropharyngeal (throat) cancer who are light smokers can be treated with radiotherapy alone and don't need chemotherapy. These folks also had a better overall outcome than people with HPV-negative throat cancer. Talk to your doctor ...

HPV is among the most common sexually transmitted diseases and can lay groundwork for developing cervical cancer. But even women who have had HPV disease can benefit from the vaccine.

One of the easiest ways to prevent more than five different kinds of cancers is to get vaccinated for HPV - but doctors may not be vaccinating boys as frequently as they should be.

A new report recommends that researchers test whether aspirin might be able to help stop cervical cancer from developing in women with HIV.

Scientists understand the big picture of how vaccines work in the body but not all the specifics at the cellular level. Now they have discovered one more piece of the puzzle.

Parents and policymakers confounded by the best practices for reducing HPV transmission could look to mathematical models to determine a good vaccination strategy for the sexually transmitted infection.

It only makes sense that, to eradicate a sexually-transmitted disease, both sexes need to be vaccinated prior to engaging in sexual activity, which would mean before puberty or early teens.

Lack of health insurance coverage may affect hepatitis C patients' access to current antiviral treatments, according to a new study.